George, D. J., Halabi, S., Fleming, M. T., Heath, E. I., Tutrone, R. F., Sutton, L., … Armstrong, A. J. (2023). A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

George, Daniel J., Susan Halabi, Mark T. Fleming, Elisabeth I. Heath, Ronald F. Tutrone, Linda Sutton, Young E. Whang, et al. “A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

George DJ, Halabi S, Fleming MT, Heath EI, Tutrone RF, Sutton L, et al. A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

George, Daniel J., et al. “A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

George DJ, Halabi S, Fleming MT, Heath EI, Tutrone RF, Sutton L, Whang YE, Lewis BE, Humeniuk MS, Berry WR, Harrison MR, Hurrelbrink J, Shobe K, Rasmussen J, Anand M, Reyes-Martinez M, Howard L, Patierno SR, Freedman JA, Armstrong AJ. A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. 2023.